Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]

        if ($this->_init && !is_writable($this->settings['path'])) {
            $this->_init = false;
            trigger_error(sprintf(__('%s is not writable', true), $this->settings['path']), E_USER_WARNING);

FileEngine::__active() - CORE/cake/libs/cache/file.php, line 267
FileEngine::init() - CORE/cake/libs/cache/file.php, line 94
Cache::_buildEngine() - CORE/cake/libs/cache.php, line 151
Cache::config() - CORE/cake/libs/cache.php, line 126
include - /home/pharma/website/releases/20120317114903/cakephp/app/pharmalicensing/config/core.php, line 345
Configure::__loadBootstrap() - CORE/cake/libs/configure.php, line 391
Configure::getInstance() - CORE/cake/libs/configure.php, line 52
include - CORE/cake/bootstrap.php, line 38
[main] - /home/pharma/website/releases/20120317114903/cakephp/webroot/pharmalicensing/index.php, line 100

Articles

Innovaro Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles
Browse

Articles

Displaying 1..10 of 21 - per page Next page
Order by

A Tour around Alzheimer's Disease

"It bothers me that I asked my daughter if she would take the clothes home with her to put them in her dryer. After she left I realised that I have my own dryer that I have been using for the past three years." More

Endo Pharmaceuticals/Vernalis' frovatriptan: The partnership of 2004

In 2004, Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award More

DrugAbuse Sciences: New Medications for Substance Abuse/Dependence

DrugAbuse Sciences was founded to improve the treatment of alcohol and drug addictions/dependence through the discovery, development, and commercialization of innovative and cost-effective medications. More

Depression - a bleak future?

In terms of world-wide sales, the current antidepressant of choice is the selective serotonin re-uptake inhibitor (SSRI) More

Bipolar Disorder Treatment Emerges from the Doldrums

Bipolar disorder—the disease previously known as manic depression—does not capture the lay or medical headlines to the same extent as schizophrenia More

BioIsrael Insight: Ester Neurosciences Challenges Conventional Wisdom

Ester Neurosciences is developing a unique, disease-modifying approach to combat neurological disorders that result from disrupted acetlycholinesterase (AChE) neuromodulation More

GB Therapeutics: Saying NO to CNS Disorders

GB Therapeutics is at the forefront of nitric oxide therapeutics research and application, having created novel nitrate drugs for the treatment of CNS and cardiovascular disorders. More

A Tour around new drugs for stroke

For years the pharmacological management of stroke languished in the shadows cast by heart dent developments this could soon change. More

Alzheimer's disease: Quest for the holy grail continues

Alzheimer's disease (AD), widely regarded as the most common cause of dementia, is a progressive neurological disorder. It can result in symptoms like memory loss, personality alterations and difficulty in communicating and performing routine tasks. More

Amarin Corporation: Focusing on CNS

A neuroscience company focused on developing novel drugs for the treatment of CNS disorders, Amarin's lead product, MiraxionTM, is in development for Huntington's disease and treatment-unresponsive depression More

Displaying 1..10 of 21 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com

Deals and alliances in central nervous system diseases

Jun 2006 - 1068 pages - $2,495

Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010

Oct 2010 - 53 pages - $1,000

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia

Sep 2011 - 97 pages - $3,500

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011

Feb 2011 - 75 pages - $1,000

Company Financials: Alexza Pharmaceuticals

Jan 2010 - $75

Emerging Technologies: Stem cells

Nov 2011 - 61 pages - $3,800

Company Financials: Cephalon, Inc

Jan 2010 - $75

Company Financials: Orexigen Therapeutics, Inc.

Jan 2010 - $75

World Market for Prescription Generic Drugs, 6th Edition

Apr 2008 - 250 pages - $3,995

Company Financials: Arena Pharmaceuticals, Inc.

Jan 2010 - $75

Your selection

Therapeutic target: Central Nervous System del

Browse By

Industry sector: Academic/Research; Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Non-profit org./Government; Pharmaceutical; Research tools; Service
Therapeutic target: Age-related disorders (other); Amyotrophic lateral sclerosis; CNS (other); Neurodegenerative disorders; Neurological; Pain; Psychiatric; Subarachnoid hemorrhage; Traumatic brain injury
Year: 2011; 2010; 2009; 2008; 2007; 2006; 2005; 2004; 2003; 2002; 2001; 2000; 1999

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

Products:

Partnering Search

Company Profiling

Pharmalicensing Intelligence

Intellectual Property

(website) 47 queries took 80 ms
Nr	Query	Affected	Num. rows	Took (ms)
1	DESCRIBE `feature_article`	13	13	1
2	DESCRIBE `feature_author`	13	13	1
3	DESCRIBE `user`	24	24	1
4	DESCRIBE `condet`	17	17	1
5	DESCRIBE `countrycode`	4	4	1
6	DESCRIBE `company`	27	27	1
7	DESCRIBE `person`	15	15	1
8	DESCRIBE `account`	29	29	1
9	DESCRIBE `product_legacy`	6	6	1
10	DESCRIBE `sales_people`	6	6	1
11	DESCRIBE `profile`	14	14	1
12	DESCRIBE `currencies`	7	7	4
13	DESCRIBE `update_rec`	7	7	1
14	DESCRIBE `dms_companies`	26	26	1
15	DESCRIBE `dms_releases`	10	10	1
16	DESCRIBE `dms_categories`	4	4	0
17	DESCRIBE `dms_clinical_areas`	4	4	0
18	DESCRIBE `dms_categories_dms_releases`	2	2	0
19	DESCRIBE `dms_clinical_areas_dms_releases`	2	2	0
20	DESCRIBE `dms_releases_sites`	5	5	0
21	DESCRIBE `licopp`	23	23	1
22	DESCRIBE `development_statuses`	5	5	0
23	DESCRIBE `category`	14	14	1
24	DESCRIBE `categories_sites`	5	5	0
25	DESCRIBE `categorisation`	8	8	1
26	DESCRIBE `licopps_sites`	3	3	0
27	DESCRIBE `service`	15	15	1
28	DESCRIBE `enquiry`	14	14	1
29	DESCRIBE `module_types`	6	6	1
30	DESCRIBE `press_release`	13	13	1
31	DESCRIBE `press_releases_sites`	5	5	0
32	DESCRIBE `story`	12	12	1
33	DESCRIBE `sites_stories`	5	5	1
34	DESCRIBE `story_assoc`	4	4	1
35	DESCRIBE `companies_sites`	3	3	1
36	DESCRIBE `categories_users`	2	2	0
37	DESCRIBE `authority`	3	3	0
38	DESCRIBE `sites_users`	5	5	1
39	DESCRIBE `sites`	5	5	1
40	SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 1	1	1	0
41	SELECT c.uid, c.name FROM category c WHERE c.parent = 297 ORDER BY c.name	11	11	0
42	SELECT c.uid, c.name FROM category c WHERE c.parent = 595 ORDER BY c.name	9	9	0
43	SELECT DISTINCT SUBSTRING(issued, 1, 4) AS publication_year FROM feature_article AS Article WHERE is_live = 1 AND issued IS NOT NULL ORDER BY publication_year DESC	13	13	5
44	SELECT c.lft, c.rgt FROM category c WHERE c.uid = 595	1	1	0
45	SELECT c.uid, c.name, c.level FROM category c WHERE c.lft <= "2999" AND c.rgt >= "3164" AND c.level > 1 ORDER BY c.level	1	1	0
46	SELECT feature_article.uid, feature_article.headline, feature_article.summary, feature_article.slug FROM feature_article INNER JOIN categorisation tt_ctg ON tt_ctg.story_id = feature_article.uid AND tt_ctg.cat_type = "F" AND tt_ctg.category_id IN (SELECT uid FROM category WHERE (lft >= 2999 AND rgt <= 3164) ) WHERE feature_article.is_live > 0 GROUP BY feature_article.uid ORDER BY feature_article.viewed_counter DESC, feature_article.headline LIMIT 0, 10	10	10	25
47	SELECT count(DISTINCT feature_article.uid) AS total FROM feature_article INNER JOIN categorisation tt_ctg ON tt_ctg.story_id = feature_article.uid AND tt_ctg.cat_type = "F" AND tt_ctg.category_id IN (SELECT uid FROM category WHERE (lft >= 2999 AND rgt <= 3164) ) WHERE feature_article.is_live > 0	1	1	19

(website) 47 queries took 80 ms

Query

Error

Affected

Num. rows

Took (ms)

DESCRIBE `feature_article`

DESCRIBE `feature_author`

DESCRIBE `user`

DESCRIBE `condet`

DESCRIBE `countrycode`

DESCRIBE `company`

DESCRIBE `person`

DESCRIBE `account`

DESCRIBE `product_legacy`

DESCRIBE `sales_people`

DESCRIBE `profile`

DESCRIBE `currencies`

DESCRIBE `update_rec`

DESCRIBE `dms_companies`

DESCRIBE `dms_releases`

DESCRIBE `dms_categories`

DESCRIBE `dms_clinical_areas`

DESCRIBE `dms_categories_dms_releases`

DESCRIBE `dms_clinical_areas_dms_releases`

DESCRIBE `dms_releases_sites`

DESCRIBE `licopp`

DESCRIBE `development_statuses`

DESCRIBE `category`

DESCRIBE `categories_sites`

DESCRIBE `categorisation`

DESCRIBE `licopps_sites`

DESCRIBE `service`

DESCRIBE `enquiry`

DESCRIBE `module_types`

DESCRIBE `press_release`

DESCRIBE `press_releases_sites`

DESCRIBE `story`

DESCRIBE `sites_stories`

DESCRIBE `story_assoc`

DESCRIBE `companies_sites`

DESCRIBE `categories_users`

DESCRIBE `authority`

DESCRIBE `sites_users`

DESCRIBE `sites`

SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 1

SELECT c.uid, c.name FROM category c WHERE c.parent = 297 ORDER BY c.name

SELECT c.uid, c.name FROM category c WHERE c.parent = 595 ORDER BY c.name

SELECT DISTINCT SUBSTRING(issued, 1, 4) AS publication_year FROM feature_article AS Article WHERE is_live = 1 AND issued IS NOT NULL ORDER BY publication_year DESC

SELECT c.lft, c.rgt FROM category c WHERE c.uid = 595

SELECT c.uid, c.name, c.level FROM category c WHERE c.lft <= "2999" AND c.rgt >= "3164" AND c.level > 1 ORDER BY c.level

SELECT feature_article.uid, feature_article.headline, feature_article.summary, feature_article.slug FROM feature_article INNER JOIN categorisation tt_ctg ON tt_ctg.story_id = feature_article.uid AND tt_ctg.cat_type = "F" AND tt_ctg.category_id IN (SELECT uid FROM category WHERE (lft >= 2999 AND rgt <= 3164) ) WHERE feature_article.is_live > 0 GROUP BY feature_article.uid ORDER BY feature_article.viewed_counter DESC, feature_article.headline LIMIT 0, 10

SELECT count(DISTINCT feature_article.uid) AS total FROM feature_article INNER JOIN categorisation tt_ctg ON tt_ctg.story_id = feature_article.uid AND tt_ctg.cat_type = "F" AND tt_ctg.category_id IN (SELECT uid FROM category WHERE (lft >= 2999 AND rgt <= 3164) ) WHERE feature_article.is_live > 0

(report) 1 query took 1 ms
Nr	Query	Error	Affected	Num. rows	Took (ms)
1	DESCRIBE `reports`		17	17	1

(report) 1 query took 1 ms

Query

Error

Affected

Num. rows

Took (ms)

DESCRIBE `reports`

(report_slave) 1 query took 1 ms
Nr	Query	Error	Affected	Num. rows	Took (ms)
1	SELECT `MarketResearchReport`.`id`, `MarketResearchReport`.`slug`, `MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`, `MarketResearchReport`.`pages`, `MarketResearchReport`.`published`, `MarketResearchReport`.`net_price_usd`, `MarketResearchReport`.`active`, `MarketResearchReport`.`publisher_id`, `MarketResearchReport`.`views`, `MarketResearchReport`.`tags`, `MarketResearchReport`.`created`, `MarketResearchReport`.`modified` FROM `reports` AS `MarketResearchReport` WHERE `MarketResearchReport`.`active` = 1 AND MATCH (`MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`) AGAINST ("Central Nervous System") ORDER BY MATCH (`MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`) AGAINST ("Central Nervous System") DESC , MarketResearchReport.published DESC LIMIT 10		10	10	1

(report_slave) 1 query took 1 ms

Query

Error

Affected

Num. rows

Took (ms)

SELECT `MarketResearchReport`.`id`, `MarketResearchReport`.`slug`, `MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`, `MarketResearchReport`.`pages`, `MarketResearchReport`.`published`, `MarketResearchReport`.`net_price_usd`, `MarketResearchReport`.`active`, `MarketResearchReport`.`publisher_id`, `MarketResearchReport`.`views`, `MarketResearchReport`.`tags`, `MarketResearchReport`.`created`, `MarketResearchReport`.`modified` FROM `reports` AS `MarketResearchReport` WHERE `MarketResearchReport`.`active` = 1 AND MATCH (`MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`) AGAINST ("Central Nervous System") ORDER BY MATCH (`MarketResearchReport`.`name`, `MarketResearchReport`.`description`, `MarketResearchReport`.`summary`, `MarketResearchReport`.`content`, `MarketResearchReport`.`isbn`, `MarketResearchReport`.`code`) AGAINST ("Central Nervous System") DESC , MarketResearchReport.published DESC LIMIT 10